HCM
MNTA

Highbridge Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Highbridge Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,900
Closed -$180K – 1899
2017
Q4 		$180K Buy
+12,900
New +$174K ﹤0.01% 1524
2016
Q2 		– Sell
-94,500
Closed -$873K – 1895
2016
Q1 		$873K Buy
+94,500
New +$1.02M 0.01% 780

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Highbridge Capital Management's MNTA Position: Q3 2014 in Review

Highbridge Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2014, closing a stake of 14,252 shares — an estimated $172K sold.

Highbridge Capital Management first reported a position in MNTA in Q3 2013 and held it in 3 quarters. The position peaked at $822K in Q1 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q3 2014.

  • Highbridge Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Highbridge Capital Management sold 14,252 Momenta Pharmaceuticals, Inc. shares in Q3 2014, an estimated $172K.
  • Highbridge Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
  • Highbridge Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $822K in Q1 2014.
  • 143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2014.

Based on Highbridge Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.